Amgen settles kickback allegations with $24.9m settlement

Amgen has settled allegations that it provided kickbacks to long-term care pharmacy providers to encourage them to use its Aranesp anaemia drug instead of a rival's, by agreeing to pay $24.9m, the US Department of Justice (DOJ) announced this week.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news